News & Articles

Expanded partnership with AstraZeneca and Daiichi Sankyo focuses on developing AI-assisted IHC assays for lung cancer biomarker analysis

Quanterix is bridging spatial biology and ultra-sensitive detection to transform cancer research and diagnostics

Collaboration focuses on education, early testing, and improved access to care for patients at risk of HDFN

Despite advances in biomarker testing, real-world data shows progress is not translating into treatment decisions, with the largest patient loss now occurring at the point of treatment decision

Hear how the Program of Glyco-Immunology and Oncology (PGIO) is deciphering cancer’s ‘glyco code’ to pave the way for more precise diagnostics and next generation immunotherapies

Acquisition strengthens Roche’s digital pathology and companion diagnostic portfolio to advance precision medicine

SPEAR overcomes immunoassay complexity and sensitivity limitations in Alzheimer’s and neurodegenerative biomarker research with a homogeneous, wash-free format

First-of-its-kind assay by Vector Laboratories and Spatomics enables simultaneous mapping of proteins and glycans on a single slide

Michael Richardson explains how Inotiv is unlocking new insights into disease mechanisms and therapeutic effectiveness using spatial transcriptomics, proteomics, and AI-powered image analytics.

New research and clinical evidence are redefining how clinicians detect and manage preeclampsia, with angiogenic biomarker testing offering earlier, clearer insight into maternal risk

Every biomarker in Aliri’s study-ready panels is carefully selected and rigorously verified for its intended biological context

Yao Chen of Sanofi shares how her team achieves sensitivity, specificity, precision, and robustness in protein biomarker detection

MOBILion Systems has shown how its proprietary PAMAF™ mode of high‑resolution ion mobility can reshape mass‑spectrometry‑based proteomics

Myalgic encephalomyelitis study identifies over 250 core genes, shared biology with long COVID, and dozens of drug repurposing opportunities

University of Cambridge researcher spotlights a novel radiotracer during ELRIG Drug Discovery 2025

Enables ultra-low variant detection across a range of key measurable residual disease targets in acute myeloid leukaemia, including very large FLT3-ITDs

Dr. Richard Knight, medical director of transplant diagnostics at Thermo Fisher Scientific explores personalized, non‑invasive approaches designed to improve transplant success

Quanterix Director of Medical Affairs discusses the advances revolutionizing Alzheimer’s diagnosis and care

Neuro-Bio is creating a first-of-its-kind diagnostic, targeting a novel biomarker in Alzheimer’s Disease

This assay allows for the quantitative measurement of soluble sTREM2 in human cerebrospinal fluid and blood within just 35 minutes

Radiometer’s blood gas and immunoassay POC analysers deliver critical parameters enabling critical care teams to make quick decisions fast

Accelerated platform delivers validated biomarkers with ready-to-use Optimer ligands in months rather than years

Revvity’s Euroimmun shares insights on the role of amyloid-beta, tau, and neurofilament in Alzheimer’s disease diagnostics

Join experts as they discuss the significant hurdles in spatial proteomics and how innovative tools such as the EVOS S1000 Spatial Imaging System are set to redefine research capabilities in this rapidly evolving field